<DOC>
	<DOCNO>NCT00482612</DOCNO>
	<brief_summary>The purpose study determine esmirtazapine ( Org 50081 ) safe effective treatment insomnia . It anticipate esmirtazapine would increase mean Total Sleep Time ( TST ) record sleep diary relative placebo .</brief_summary>
	<brief_title>Study Safety Effectiveness Esmirtazapine Participants With Chronic Primary Insomnia ( P05706 )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<criteria>Has sign write informed consent scope nature investigation explain Has difficulty fall asleep , maintain sleep early morning awakening Significant medical psychiatric illness cause sleep disturbance Has history bipolar disorder family ( immediate family ) suicide Has sleep disorder sleep relate breathe disorder , restless leg syndrome , narcolepsy Has significant medical illness acute chronic pain , heart , kidney liver disease within last year Currently diagnose meet criteria Major Depressive Disorder ( MDD ) treat MDD last 2 year Substance abuse , excessive use alcohol ( determined physician ) drug addiction within last year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>